# GRAIL's Galleri test wins endorsement from FDA panel — retained record

> Retained news record from news:seeking-alpha.

Canonical: https://highsignal.app/data/records/a325f2c2f879f4ed

[← sources](https://highsignal.app/data)


source: [news](https://highsignal.app/data/news) (news:seeking-alpha)  published 2026-09-24 00:57 ingested 2026-09-24 02:52

[original source ↗](https://seekingalpha.com/news/4646404-grail-galleri-test-wins-endorsement-from-fda-panel?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news)

## retained text



```
Search fieldHome page Seeking Alpha - Power to InvestorsSearch for Symbols, analysts, keywordsAbout PremiumCreate free accountLog in

GRAIL's Galleri test wins endorsement from FDA panel

Sep 23, 2026, 8:57 PM ETGRAIL, Inc. (GRAL) StockBy : Jonathan Block, SA News Editor

A panel of US FDA advisors voted that there is reasonable evidence that GRAIL’s (GRAL) multi-cancer early detection blood test Galleri is effective. The vote was 6-4.

Members of the Molecular and Clinical Genetics Panel of the Medical Devices Advisory

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Search fieldEntering text into the input field will update the search result below
```



document fetched 2026-09-24 02:52 · canonical https://seekingalpha.com/news/4646404-grail-galleri-test-wins-endorsement-from-fda-panel?feed_item_type=news